Leonie Dupuis

Leonie Dupuis

Auto-generated profile, based on publicly available information

Leonie Dupuis

Vanderbilt University Medical Center

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2024 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
HPHet Patel
Het Patel
LDLeonie Dupuis
Leonie Dupuis
MBMatthew Bacchetta
Matthew Bacchetta
AHAntonio Hernandez
Antonio Hernandez
MKManreet K. Kanwar
Manreet K. Kanwar
ARAniket S. Rali
Aniket S. Rali
Utilization of temporary mechanical circulatory support, including veno-arterial extra-corporeal membrane oxygenation as a bridge to heart transplantation (HT) has increased significantly under the revised United Network for Organ Sharing (UNOS) donor heart allocation system. The revised heart allocation system aimed to lower waitlist times and mortality for the most critically ill patients requiring biventricular, nondischargeable, mechanical circulatory support. While previous reports have shown improved 1-year post-HT survival in the current era, 3-year survival and factors associated with mortality among bridge-to-transplant (BTT) extra-corporeal membrane oxygenation (ECMO) patients are not well described. We queried the UNOS database for all adult (age ≥ 18 years) heart-only transplants performed between 2010 and 2019. Patients were stratified as either pre- (January 2010-September 2018; era 1) or post-allocation change (November 2018-December 2019; era 2) cohort based on their HT date. Baseline recipient characteristics and post-transplant outcomes were compared. A Cox regression analysis was performed to explore risk factors for 3-year mortality among BTT-ECMO patients in era 2. For each era, 3-year mortality was also compared between BTT ECMO patients and those transplanted without ECMO support. During the study period, 116 patients were BTT ECMO during era 1 and 154 patients during era 2. Baseline recipient characteristics were similar in both groups. Median age was 48 (36-58 interquartile range (IQR)) years in era 2, while it was 51 (27-58 IQR) years in era 1. The majority of BTT-ECMO patients were males in both era 2 and era 1 (77.7% vs 71.5%, p = 0.28). Median ECMO run times while listed for HT were significantly shorter (4 days vs 7 days, p < 0.001) in era 2. Waitlist mortality among BTT ECMO patients was also significantly lower in era 2 (6.3% vs 19.3%, p < 0.001). Post-HT survival at 6 months (94.2% vs 75.9%, p < 0.001), 1 year (90.3% vs 74.2%, p < 0.001), and 3 years (87% vs 66.4%, p < 0.001) was significantly improved in era 2 as compared to era 1. Graft failure at 1 year (10.3% vs 25.8%, p = 0.0006) and 3 years (13.6% vs 33.6%, p = 0.0001) was also significantly lower in era 2 compared to era 1. Three-year survival among BTT ECMO patients in era 2 was similar to that of patients transplanted in era 2 without ECMO support (87% vs 85.7%, p = 0.75). In multivariable analysis of BTT-ECMO patients in era 2, every 1 kg/m2 increase in body mass index was associated with higher mortality at 3 years (hazard ratio (HR) 1.09, 95% CI 1.02-1.15, p = 0.006). Similarly, both post-HT stroke (HR 5.58, 95% CI 2.57-12.14, p < 0.001) and post-HT renal failure requiring hemodialysis (HR 4.36, 95% CI 2.43-7.82, p < 0.001) were also associated with 3-year mortality. Three years post-HT survival in patients bridged with ECMO has significantly improved under the revised donor heart allocation system compared to prior system. BTT ECMO recipients under the revised system have significantly shorter ECMO waitlist run times, lower waitlist mortality and 3-year survival similar to those not bridged with ECMO. Overall, the revised allocation system has allowed more rapid transplantation of the sickest patients without a higher post-HT mortality.

1 November 2023 in Advances in Kidney Disease and Health
Verified
Journal Article
Closed access
JBJohn Sebastian Babich
John Sebastian Babich
LDLéonie Dupuis
Léonie Dupuis
KKKamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh
SJShivam Joshi
Shivam Joshi

24 June 2023 in Nutrition Reviews
Verified
Journal Article
Closed access
PDF file
AVAarushi Varshney
Aarushi Varshney
LDLeonie Dupuis
Leonie Dupuis
MAMonika Aggarwal
Monika Aggarwal
SJShivam Joshi
Shivam Joshi
This Letter to the Editor is a response to St-Jules and Fouque and their interpretation of postprandial hyperkalemia, especially regarding plant-based diets. Based on the reviewed literature review, potassium kinetic studies cited by the authors include only 1 study with a food-based intervention that actually showed reduced postprandial hyperkalemia with plant-based diets. The remainder of the studies used potassium salts or supplements that behave differently compared with whole plant foods. As such, we recommend avoiding restriction of whole plant foods in patients with chronic kidney disease when solely based on the theoretical risk of postprandial hyperkalemia.

9 July 2024 in Journal of Renal Nutrition
Verified
Journal Article
Closed access
JBJohn Sebastian Babich
John Sebastian Babich
JPJason N Patel
Jason N Patel
LDLéonie Dupuis
Léonie Dupuis
DGDavid S. Goldfarb
David S. Goldfarb
SLStacy Loeb
Stacy Loeb
SJShivam Joshi
Shivam Joshi

19 February 2025 in Cardiac Failure Review
Verified
Journal Article
Open access
PDF file
ASAlexander E Sullivan
Alexander E Sullivan
HGHannah Granger
Hannah Granger
LDLeonie Dupuis
Leonie Dupuis
JNJonathan Napper
Jonathan Napper
LTLena Tran
Lena Tran
ARAniket S Rali
Aniket S Rali
Introduction: Percutaneous ventricular assist devices (pVADs) are increasingly used in cardiogenic shock but are associated with complications including haemolysis. The aim of this study was to investigate patient characteristics associated with haemolysis in cardiogenic shock patient population. Methods: Consecutive patients were identified using Current Procedural Terminology (CPT) codes for pVAD insertion. Patient characteristics, laboratory and imaging data, and patient outcomes were abstracted manually and using validated automated methods. Laboratory-defined haemolysis required a drop in haemoglobin ≥2 mg/dl with either lactate dehydrogenase ≥250 units/l or undetectable haptoglobin. Clinically significant haemolysis was defined as laboratory-defined haemolysis necessitating transfusion. Primary outcome was the association between haemolysis and on-device and 30-day mortality. Results: A total of 196 patients underwent pVAD insertion for cardiogenic shock during the study period and were included. Laboratory-defined haemolysis occurred in 46 patients (23.5%), of whom 12 (6.1%) had clinically significant haemolysis. Haemolysis occurred more often following emergency insertion, rather than elective insertion (84.8% versus 40.0%, p<0.001) in patients with elevated lactic acid levels (median 2.5 versus 1.6, p=0.016) and elevated heart rates (92.5 BPM versus 86.5 BPM, p=0.023). After multivariable adjustment, there was no association between laboratory-defined haemolysis and on-device (OR 0.6; 95% CI [0.1–3.4]; p=0.565) or 30-day mortality (OR 2.1; 95% CI [0.4–13.0]; p=0.391). Conclusion: Laboratory-defined haemolysis was common in patients with cardiogenic shock and pVAD, but clinically significant haemolysis was not. There was no association between haemolysis and on-device or 30-day mortality.

18 February 2023 in American Journal of Lifestyle Medicine
Verified
Journal Article
Closed access
LDLéonie Dupuis
Léonie Dupuis
AMAnabella Munoz
Anabella Munoz
SWSharon M Wasserstrom
Sharon M Wasserstrom
Montverde Academy is home to our country’s first Lifestyle Medicine Club, a novel approach to Lifestyle Medicine outreach amongst teenagers. A high-school student-driven initiative, the club successfully completed its first year in existence by focusing on growing its membership and teaching high school students about the 6 pillars of Lifestyle Medicine. This article describes the inception of the club, its first events, and its future directions.